China Sky One Medical, Inc. 

(Public, NASDAQ:CSKI)   Watch this stock   
Find more results for AMEX:CSY
Nov 17, 2009
Q3 2009 CHINA SKY ONE MEDICAL, INC. Earnings Release
Nov 17, 2009
Q3 2009 CHINA SKY ONE MEDICAL, INC. Earnings Conference Call
Sep 23, 2009
CHINA SKY ONE MEDICAL, INC. Annual General Meeting
Sep 10, 2009
CHINA SKY ONE MEDICAL, INC. at Rodman & Renshaw Annual Global Investment Conference
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 29.39% 31.43%
Operating margin 37.55% 38.84%
EBITD margin - 39.77%
Return on average assets 33.05% 41.66%
Return on average equity 35.44% 45.38%
Employees 1,804 -

Address

Room No. 1706, No 30 Di Wang Building, Gan Shui Road Nangang District
Harbin, HNG 150001
China
+86-451-53994073 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

China Sky One Medical, Inc. discussed on blogs

Ranking 142 Chinese ADRs by Year-to-Date Performance - China ... - Investor's Resources - China Analyst - News and Research on US-Listed Chinese Stocks - 16 hours ago
Ranking All U.S. Stocks by Weekly Performance - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 17 hours ago

China Sky One Medical, Inc. discussions

  View all discussions »

Description

China Sky One Medical, Inc. is engaged in the development, manufacture, marketing and sale of over-the-counter, branded nutritional supplements and over-the-counter plant and herb based pharmaceutical and medicinal products. Its principal products are external use Traditional Chinese Herbal Remedies/Medicines (TCM). The Company is also an integrated manufacturer, marketer and distributor of external use Chinese medicine products sold primarily in China and through Chinese domestic pharmaceutical chains. The Company sells both its own manufactured products, as well as medicinal and pharmaceutical products manufactured by others in China. All of its business is conducted through its wholly owned subsidiary, American California Pharmaceutical Group, Inc. (ACPG) which, in turn, wholly owns Harbin Tian Di Ren Medical Science and Technology Company (TDR). On April 3, 2008, TDR completed its acquisition of Heilongjiang Tianlong Pharmaceutical, Inc.

Officers and directors

Yan-qing Liu
President, Chief Executive Officer, Director
Age: 44
Bio & Compensation - Reuters
Xiao-yan Han
Vice Chairman of the Board
Age: 41
Bio & Compensation - Reuters
Yu-bo Hao
Chief Financial Officer, Secretary, Director
Age: 38
Bio & Compensation - Reuters
Chun Fan Song
Director
Age: 69
Bio & Compensation - Reuters
Jie Zhao
Director
Age: 46
Bio & Compensation - Reuters
Xu Feng Qian
Director
Age: 41
Bio & Compensation - Reuters
Wei Lee
Director
Age: 55
Bio & Compensation - Reuters